NCT06467539View on ClinicalTrials.gov

Novel Augmentation of DAOIB and Antioxidant for Early Dementia

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DRUG

DAOIB plus AO

oral, for 24 weeks

DRUG

DAOIB plus placebo

oral, for 24 weeks

Trial Locations (1)

886

RECRUITING

Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER